Pathos AI — Tempus oncology AI training data license (2025)
Tempus licenses de-identified multimodal data to Pathos for an oncology foundation model. The $50 million upfront payment is included in the $200 million license fees.
Contract facts
Source per value- DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
- 2025-04-171
- BuyerThe purchasing organisation or named customer.
- Pathos AI1
- VendorThe contracting supplier or AI provider, as named in the source.
- Tempus AI1
- SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
- Enterprise
- Value $Dollar value exactly as the source states it: an award, order, licence fee or customer commitment. Empty when undisclosed. The summary says what the figure covers; figures can include non-AI services.
- $200,000,0001
- Upfront payment $Upfront payment stated for research and licence collaborations.
- $50,000,0001
- Term yearsStated length of the agreement in years; decimals keep the source's own duration.
- 31
Sources
- sec.gov accessed 2026-11-11
Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.
Related contracts
All 87 contracts-
AstraZeneca — Tempus oncology model statement of work (2025)
AstraZeneca AB · Tempus AI
$35M stated value -
Mayo Clinic — Abridge enterprise clinical documentation agreement (2025)
Mayo Clinic · Abridge
Undisclosed -
Seattle Children's — Abridge clinical AI agreement (2025)
Seattle Children's · Abridge
Undisclosed -
Quest Diagnostics — PathAI software and algorithm licensing (2024)
Quest Diagnostics · PathAI
Undisclosed -
Moderna — OpenAI enterprise collaboration (2024)
Moderna · OpenAI
Undisclosed
Spot a change?
Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.